Ticks and tick-borne pathogens have evolved together, resulting in a complex relationship in which the pathogen's life cycle is perfectly coordinated with the tick's feeding cycle, and the tick can harbour high pathogen levels without affecting its biology. Tick-borne diseases (TBDs) continue to emerge and/or spread, and pose an increasing threat to human and animal health. The disruptive impacts of global change have resulted in ecosystem instability and the future outcomes of management and control programmes for ticks and TBDs are difficult to predict. In particular, the selection of acaricide-resistant ticks has reduced the value of acaricides as a sole means of tick control. Vaccines provide an alternative control method, but the use of tick vaccines has not advanced since the first vaccines were registered in the early 1990s. An understanding of the complex molecular relationship between hosts, ticks and pathogens and the use of systems biology and vaccinomics approaches are needed to discover proteins with the relevant biological function in tick feeding, reproduction, development, immune response, the subversion of host immunity and pathogen transmission, all of which mediate tick and pathogen success. The same approaches will also be required to characterise candidate protective antigens and to validate vaccine formulations. Tick vaccines with a dual effect on tick infestations and pathogen transmission could reduce both tick infestations and their vector capacity for humans, animals and reservoir hosts. The development of integrated tick control strategies, including vaccines and synthetic and botanical acaricides, in combination with managing drug resistance and educating producers, should lead to the sustainable control of ticks and TBDs.
The economic loss due to ticks and tick-borne diseases (TBDs) is estimated to be billions of dollars annually (8) . Throughout the complex tick life cycle, from the egg to the larva, nymph and adult stages, the quantity of blood required increases at each stage and the duration of feeding required by females lengthens from 7 to 14 days. These prolonged feeding periods contribute to a wide range of host impacts, and tick infestations alone can cause tick paralysis, allergic reactions and tick-based toxicosis, damage to hides, secondary infections, septicaemia, reductions in weight gain, decreased milk production and/ or abortion (9, 10, 11) . Despite the use of modern medical and veterinary treatments, the widespread use of acaricides and the development of new methods of tick control, longterm attempts to limit the geographic expansion of ticks or to reduce their populations in specific areas have been remarkably unsuccessful. The enormous reproductive capacity of ticks, in which one fully engorged female can produce 5,000 to 10,000 eggs, allows tick populations to rapidly rebound.
Ticks as vectors of pathogens
Ticks were the first arthropods to be clearly established as vectors of disease-causing pathogens, and they transmit a wider variety of pathogenic microbes to humans and animals than any other arthropod (12) . In the historic discovery by Smith and Kilbourne (13) , Boophilus annulatus (recently reclassified as Rhipicephalus [Boophilus] annulatus) was shown to be the vector of Babesia bigemina, the protozoan that causes Texas cattle fever. Thereafter, other arthropods were found to act as vectors for pathogens. They include fleas, which carry Yersinia pestis, the bacterial agent of plague, and mosquitoes, which transmit yellow fever virus, filariosis and Plasmodium sp., the aetiologic agent of malaria.
Since these early discoveries of TBDs, a growing list of others has unfolded, including rickettsial spotted fevers, viral encephalitis and haemorrhagic fevers, Colorado tick fever and Kyasanur Forest disease, Q fever, ehrlichiosis, anaplasmosis and babesiosis (14) . Lyme borreliosis was a notable TBD discovered in the 1970s, which was followed by the emergence of Babesia microti, the aetiologic agent of human babesiosis, in the 1980s. Since 2000, the emergence of human granulocytic anaplasmosis caused by Anaplasma phagocytophilum has been reported in the United States (USA) and is currently also an emerging disease of humans in Europe and other areas of the world. The latest emerging TBD, Bourbon virus, was reported in Kansas in 2014 (15) . More than 16 specific TBDs of humans and 19 TBDs of livestock and companion animals have been described (16, 17) and this trend of the emerging TBD will most likely continue.
Ticks and the pathogens that they transmit have co-evolved, resulting in a complex relationship which is complementary to both the tick host and pathogen. The infection and transmission cycle of tick-borne pathogens is perfectly coordinated with the tick' s feeding cycle. Ticks can harbour high pathogen levels without adverse effects on their biology and so pathogen infections do not affect their population densities.
Impact of global change on ticks and tick-borne pathogens
While the increase in tick populations and the emergence of TBDs is not fully understood, global change has increased the vulnerability of human and animal populations to emerging and re-emerging TBDs (18, 19) . Global change, defined as the environmental and climatic changes ascribed to human activity, includes disruptive processes that result in the instability of ecosystems and contribute to the uncertainty of future outcomes of management and control strategies for ticks and TBDs. Such disruptive processes affect the epidemiology of TBDs and may result in the emergence and re-emergence of ticks and TBDs (19, 20) . The array of impacts of global change include the alteration of ecosystems and agro-ecosystems, incursions into natural habitats by humans and animals, shifts in land use, the movement of people and animals, the unrestricted importation of plants and animals, shifts in bird migration patterns, climate change, the selection of acaricideresistant ticks, increased international trade and travel, civil unrest, the expansion of tick and TBD host ranges and governmental and/or management failure (21, 22, 23) . In addition, tick control efforts have been disrupted by a deterioration in public safety, such as the illegal drug activities which have interrupted the control efforts of the Cattle Fever Tick Eradication Program (CFTEP) in and around quarantine areas in south Texas that border on Mexico (24) . These impacts, compounded by the zoonotic nature of some TBDs, have presented public health and central veterinary authorities with the unexpected challenges and consequences of global change (24) . Climate change alone has transformed some areas into habitats suitable for ticks and wildlife hosts. An underappreciated factor that has contributed to the increase of tick species and TBDs is the accidental importation of ticks on exotic animals during the international trade of live animals and reptiles, and the movements of travellers and their baggage, animal products, plant material and migratory birds. One study (25) recently detailed the unrestricted introduction of 100 non-native ticks into the USA over the past 50 years. Some of these imported ticks have the potential to transmit TBDs that could have an enormous impact on humans and food animal production.
Tick eradication campaigns: successes, failures and lessons learned
Controlling ticks is difficult because they have few natural enemies and are not susceptible to immediate 'knockdown' effects. Control efforts are compounded by the complex tick life cycle, their enormous reproductive capacity and the number of hosts (one, two or three) that are required to complete the life cycle. Long-term attempts to limit geographic expansion or to decrease the size of tick populations responsible for human disease have been remarkably unsuccessful, with the exception of the widespread use of acaricides for the eradication of R. (Boophilus) microplus during the CFTEP campaign in the southern USA during the early 1900s, and of Ixodes persulcatus and tick-borne encephalitis in the former Soviet Union from 1965 to 1971 (26) . However, the limitations of chemical control have now been realised since the intensive and repeated use of acaricides, the centrepiece of these control attempts, has resulted in the selection of acaricideresistant ticks.
Insight into the challenges of tick control was provided by two large-scale tick eradication campaigns: the CFTEP to eradicate R. (Boophilus) microplus and the programme to eradicate Amblyomma variegatum in the French West Indies and Puerto Rico.
The Cattle Fever Tick Eradication Program
The CFTEP tick control campaign was begun in the early 1900s in the southern USA to eradicate R. (Boophilus) microplus. This tick species is the vector of B. bigemina and B. bovis, the aetiologic agents of Texas cattle fever, and Anaplasma marginale, which causes bovine anaplasmosis. In addition to the damage caused by tick infestations, these two diseases have also had a severe impact on cattle production and resulted in enormous economic losses (9, 10, 11) .
The programme to eradicate Amblyomma variegatum
The tropical bont tick, Amblyomma variegatum, was introduced onto the Caribbean island of Guadeloupe in the early 1800s. The French West Indies and Puerto Rico were targeted in the 1990s because of this species' impact on local livestock production and the threat of its introduction into the USA. Amblyomma variegatum is the vector of Ehrlichia rumiantium, the causative agent of heartwater disease in ruminants (also known as cowdriosis), and the threat of introduction of this tick/disease into the cattle population in the USA continues to be of great concern.
Lessons learned
Tick control by the application of acaricides was the centrepiece of both these tick campaigns because of its immediate effect and because this is a cost-effective means of reducing tick populations. The Cattle Fever Tick Eradication Program had the advantage that R. (Boophilus) spp. are one-host ticks that parasitise and complete their life cycle on a single host, with cattle as that preferred host, whereas the life cycle of the three-host tick A. variegatum involves multiple host species. Therefore, CFTEP could be focused wholly on the treatment of cattle. The bont tick campaign fell short of its goal because the systematic programme and supply of acaricides were interrupted when donor countries withdrew funding. More recently, slowrelease tags impregnated with an aggregation-attachment pheromone and acaricide have been tested and show promise if the issues raised by this control method can be addressed (27) .
The intensely orchestrated CFTEP campaign resulted in the declared eradication of R. microplus in most southern states by 1943. However, complete eradication was not possible along the border of Texas and Mexico, and small outbreaks continued to occur. In recent years these outbreaks have dramatically increased due to the complex series of impacts of global change (28), the most notable of which are the selection of ticks resistant to multiple acaricides (29) , the role of white-tailed deer (Odocoileus virginianus) as alternative hosts for the cattle fever tick (30), changes in human populations and land use, climate change, and the impact of cartel violence on control efforts (24) .
The overriding problem of the selection of acaricideresistant ticks has also been reported in tick control efforts worldwide, including those in Australia, Africa, Mexico, South America and the Middle East (29, 31, 32) . The continued use of acaricides in tick control campaigns is now dependent on the identification of resistance markers in ticks and the periodic monitoring of tick populations for resistance against multiple acaricides. Clearly, all of these attempts to control or eradicate ticks have demonstrated that long-term and consistent commitment is required for tick control and that the eradication of any tick species is not likely to be a realistic goal.
Development of vaccines for control of tick infestations
New approaches for tick control depend upon defining the molecular interactions between hosts, ticks and pathogens, to enable the discovery of key molecules that could be tested for their ability to intervene in tick-pathogen cycles (33). Tick vaccines offer the important advantage of being a cost-effective and environmentally friendly alternative, with a dual effect of reducing tick infestations and preventing ticks from transmitting disease-causing pathogens. Tick antigens studied thus far have demonstrated multiple tick impacts when used in a vaccine format. These include reductions in: -tick infestations and fertility -pathogen infection -vector capacity for pathogen transmission -tick response to pathogen infection.
Importantly, the limited use of cattle tick vaccines has demonstrated our greatly reduced dependence on acaricides, which lowers the risk of the selection of acaricide-resistant populations (34, 35). Characterisation of the molecular mechanisms that mediate tick-pathogen and tick-host interactions will probably provide new targets for vaccines to reduce tick infestations and tick vector competency for pathogens (33, 36, 37) . Recent research has provided evidence that the co-evolution and long-term survival of ticks and TBDs involve the genetic traits of both ticks and pathogens in which pathogen ligands and tick receptors enable the pathogenic infection of ticks (38, 39). The use of Bm86-based tick vaccines resulted in a reduction in the number, weight and reproductive capacity of engorging female ticks, and so the greatest effect of these vaccines is their reduction of tick infestations in subsequent generations (35) . Experimental data and model systems have shown that a vaccine efficacy greater than 50% is sufficient to reduce larval infestations in subsequent generations without eradicating ticks (48, 50, 51, 52, 53, 54).
The historical perspective

Discovery and characterisation of new tick protective antigens
The experience with Bm86-based vaccines revealed the need for the development of improved tick vaccines. However, the identification of tick protective antigens has been the limiting factor in this approach. The critical step of the identification and characterisation of novel tick protective antigens requires the implementation of high-throughput methods. Tick protective antigens have been identified by: -the evaluation of proteins after host immunisation and tick challenge that were derived from the progressive fractionation of crude tick extracts (41, 55) -immunomapping of tick antigens that elicit an antibody response in an infested host, or with antibodies against tick tissue extracts (56, 57, 58, 59, 60, 61) -reverse genetics and testing tick proteins that were considered important for tick feeding and reproduction and for the parasite' s function and/or survival (33, 54).
Recently, new and exciting possibilities for predicting, screening and identifying protective antigens against tick infestations (62) have been provided through complementary DNA (cDNA), expressed sequence tags and genome and proteome databases (e.g. those of the National Center for Biotechnology Information, VectorBase, and the Exon distribution server of the National Institute of Allergy and Infectious Diseases) of different tick tissues, their developmental stages, and the genes expressed in response to various stimuli (i.e. tick feeding or infection with pathogens). The prediction of tick protective antigens can now also be carried out in silico, using defined selection criteria and bioinformatics tools (63, 64, 65, 66) . Screening platforms used to identify tick protective antigens include expression library immunisation (67), suppression subtractive hybridisation (68) , in vitro tick feeding systems such as capillary feeding (69, 70, 71) , and RNA interference (RNAi) (72, 73, 74) . RNA interference has become the most important tool for genetic manipulation in ticks (75, 76) , and this approach might also enable the identification of antigens that interfere with pathogen development and transmission (77, 78) .
Since the 1980s, many tick protein extracts and subunits have been proposed as protective antigens for the control of tick infestations (79). However, only some of these antigens have been evaluated in vaccination experiments, which is necessary for their validation as candidate tick protective antigens. Some putative vaccine antigens failed to protect hosts against tick infestation (80, 81, 82), possibly because they were expressed at low levels or were inaccessible to host antibodies. Over the course of their evolution, ticks have most probably developed mechanisms to counteract the effects of the host immune response, particularly for exposed antigens. These mechanisms might include immunosuppressive molecules secreted during tick feeding and multi-gene families with redundant biological functions (83, 84, 85 
Dual vaccines for controlling tick infestations and the transmission of tick-borne pathogens
Vaccine trials with Bm86-based vaccines resulted in a reduction in the incidence of babesiosis and the transmission of Babesia spp. where the target ticks were the main vectors. The reduction of bovine anaplasmosis was not as notable, most probably because this pathogen is also transmitted mechanically by the blood-contaminated mouthparts of biting insects and fomites (34).
Tick-pathogen co-evolution involves the genetic traits of both the vector and the pathogen (39 78, 101, 102, 103, 104, 105, 106, 107, 108, 109) . Genes differentially expressed in response to pathogen infection were used for RNAi studies to discover their function during infection. Some genes were shown to encode for proteins involved in tick defences to limit pathogen infection, while the expression of other genes was manipulated by the pathogen to increase infectivity (77, 78, 101) . Differential gene expression in response to microbial infection has also been shown for I. ricinus and I. scapularis with B. burgdorferi (110, 111) ; D. variabilis with Rickettsia montanensis (112, 113) ; R. appendiculatus with Theileria parva (114) , and R. microplus with B. bovis (115) . The genes involved in tick-pathogen interactions are good candidates for the development of vaccines to control pathogen transmission (39). In addition, suppressing the gene products required for pathogen infection, multiplication and transmission should reduce the tick vectorial capacity, and suppressing the tick antimicrobial response might result in higher pathogen infection levels that would be detrimental to the tick.
Recent experiments have illustrated how vaccination with tick antigens also affects tick vector capacity. Labuda et al. (116) and de la Fuente et al. (117) reported that the vaccination of mice with 64P and subolesin antigens prevented the transmission of tick-borne encephalitis virus by I. ricinus and decreased I. scapularis infection by A. phagocytophilum, respectively. Jeyabal et al. (118) provided evidence that cattle vaccination with the Bm86 orthologue of Hyalomma anatolicum anatolicum, Haa86, might reduce tick transmission of T. annulata. Antibodies against the I. scapularis salivary protein Salp15 protected mice from the Lyme disease agent B. burgdorferi that binds to this protein to facilitate tick transmission and host infection (119) . Cattle vaccination with recombinant subolesin reduced R. microplus infection levels with A. marginale and B. bigemina (92, 120) . Recently, a vaccine trial on cattle and sheep farms in Sicily demonstrated the effect of subolesin on tick infestations and weight and on the prevalence of some tick-borne pathogens and pathogen genotypes (121). These experiments demonstrated that tick vaccines might contribute to the control of tick-borne pathogens by decreasing the exposure of susceptible hosts to ticks and by reducing tick vectorial capacity (35, 54, 92, 122, 123) . Therefore, the development of dual-target recombinant vaccines could be directed towards the control of both ticks and tick-borne pathogens.
New vaccine formulations
Although this field is less advanced than other research areas, the development of new expression systems and cost-effective processes to produce recombinant antigens is essential for the successful and economical production of tick vaccines (124) . Research in this area should be directed towards reducing production costs while increasing the yield and efficacy of vaccine antigens (124, 125, 126, 127, 128, 129) .
The identification of protective antigens conserved across tick species provides an opportunity to develop vaccines to protect hosts against infestations by multiple tick species (91) . As discussed previously (91, 130) , tick antigens such as subolesin/akirin conserved among arthropod vectors may also be conserved in vertebrate hosts, raising the question of safety because of the potential for inducing autoimmune responses that might be damaging to the host. However, it is expected that the antibody response would be primarily directed against non-self epitopes, thereby reducing the possibility of detrimental effects to the host.
Research on sugar epitopes in tick proteins and their potential use for controlling tick infestations and pathogen transmission is still in its infancy. However, carbohydrate targets might lead to a universal transmission-blocking vaccine for the control of multiple pathogens (131, 132) .
Other possibilities for improving the efficacy of vaccine formulations are the development of improved adjuvants and rational antigen design. Adjuvant research for tick vaccines is needed to improve vaccine efficacy, in order to extend the duration of the antibody response and thus the period of protection in vaccinated hosts (133, 134 ). An example of rational antigen design is the evaluation of chimeric antigens containing protective epitopes from Bm86 (125, 128, 135) and from tick subolesin and mosquito akirin (93, 94, 130, 136) . The subolesin/akirin chimeric antigen might be useful for developing vaccines to control multiple arthropod vector infestations (91, 94) . The possible drawbacks of this approach include the induction of antibodies with specificities different from those induced by the native protein and the selection of escape mutants by oligoclonal antibodies produced in vaccinated hosts, although this might not be a problem if mutation is constrained by the functional requirements of the protein (91).
Additional approaches considered for tick control
Wildlife has been shown to play an essential role in sustaining and expanding tick populations (137, 138) . Thus, tick control interventions that could efficiently be applied to wildlife may be essential for tick control in some regions. These interventions could include the application of acaricides (139) , wildlife host management (140), autocidal control (141, 142) and vaccination (143) , which have been proven to effectively control tick populations under field and/or controlled conditions. However, additional developments are required before tick control can effectively be applied to wildlife to reduce the impact of ticks on human health and animal health and production. For example, the development of oral vaccine formulations, similar to those under investigation for tuberculosis control in wildlife, could contribute to the application of vaccination programmes to deer and other wild tick hosts (144, 145) .
Biological control of ticks using entomopathogenic fungi and nematodes has been demonstrated under laboratory conditions but further research is needed to prove its efficacy and practical application under field conditions (146, 147, 148, 149) . Although the presence of some insect, spider and plant species has been associated with lower or higher levels of tick infestation (see, for example, 150, 151), the use of these organisms for tick control has not been proven and is unlikely to succeed, due to the fact that ticks have very few natural enemies and can still reach a high prevalence in their presence if the appropriate hosts are available.
Recently, research into the discovery and characterisation of botanical acaricides has begun to promise possibilities for more effective and environmentally friendly acaricides for tick control (152) .
Future strategies for tick control
New tick control strategies are urgently needed because ticks and TBDs will most likely continue to emerge and/or spread to new areas of the world, posing an ever-increasing threat to human and animal health. Complete tick eradication does not appear to be a realistic goal. Moreover, tick eradication remains a controversial issue because it might result in the elimination of enzootic stability for tick-borne pathogens, which would result in highly susceptible host populations for tick-borne pathogens and their associated diseases. Additionally, tick eradication might be difficult to sustain during conditions favourable for tick population expansion (21, 153, 154, 155, 156) . It would also reduce biodiversity and the arsenal of bioactive compounds that might be isolated from ticks (83-157).
However, the control and reduction of tick populations is possible by employing control programmes with integrated and consistent approaches (158, 159) . The most successful tick control programmes are those that have been mandated and carried out by governments, involving regimented programmes with careful monitoring of tick populations. This integrated approach could include the use of vaccines, synthetic and botanical acaricides, producer education and the monitoring and management of drug resistance as well as of tick and host populations. Reducing our dependence on acaricides will also reduce their drawbacks -the selection of resistant ticks, environmental contamination and toxic reactions in animals and humans -as well as reducing the expense of treatment. The complicated nature of current and future problems driven by global change requires that societal, environmental, scientific and policy considerations be integrated to develop the most effective and sustainable strategies and goals to prevent increases in tick populations and outbreaks of TBDs (29) .
Tick vaccines have been shown to be a cost-effective and environmentally sound approach to tick control. After more than a decade of commercial tick vaccine use in the field, effective control of cattle tick populations has been achieved, accompanied by improved cattle production and reduced dependence on acaricides. The long-term benefits of reduced acaricide use are considerable and include environmental and health considerations and reduced selection of resistant ticks from repeated acaricide treatments (160) . If the rate of selection of acaricide-resistant ticks can be decreased, the useful life of an acaricide will be prolonged, providing a further control option until more effective tick vaccines are developed. Additionally, although it might be possible for ticks to develop resistance to tick vaccines, it is highly unlikely because of the polyclonal nature of the protective antibody response (161) . Together, these results support the importance of tick vaccines in integrated control strategies in regions where acaricide-resistant ticks have already or may become a major problem for the cattle industry.
The development of improved vaccines in the future will be greatly enhanced by molecular technologies and systems biology approaches that are already contributing to the characterisation of tick-pathogen and tick-host interactions (33). The discovery of new candidate vaccine antigens for the control of tick infestations and pathogen transmission requires the development of effective screening platforms and algorithms that allow the analysis and validation of data produced through systems biology approaches to tick research. The combination of tick-derived and pathogen-derived antigens may result in more effective vaccines to control TBDs. Tick vaccines that reduce both tick infestations and pathogen transmission could be used to vaccinate human and animal populations at risk, so as to reduce host exposure to ticks while also reducing the number of infected ticks and their vectorial capacity for pathogens that affect human and animal health worldwide.
In the future, transgenic or paratransgenic ticks (36), genetically modified tick-borne pathogens (162) and vertebrate hosts which have been genetically modified to confer resistance to pathogen infection may be produced and combined with other tick control interventions.
Effective integrated pest management programmes and modelling programs that take vaccines into account should be developed and implemented, with the aid of government intervention in some countries, as needed. Recent publications and patents show a growing trend in tick control research with about one-quarter of this effort devoted to tick vaccines (Fig. 1) . Although the lack of funding and commercial interest might be a limiting factor for the development of new tick control tools, the growing need for improved, effective and environmentally sound methods for tick control should motivate producers, stakeholders, scientists and the general public to achieve this goal. Resumen Las garrapatas y los patógenos que transmiten han evolucionado conjuntamente, lo que ha desembocado en una compleja relación en la cual el ciclo vital del patógeno está perfectamente coordinado con el ciclo de alimentación de la garrapata, que puede albergar un elevado nivel de patógenos sin que su biología resulte afectada. Las enfermedades transmitidas por garrapatas siguen surgiendo y/o propagándose, hecho que entraña una creciente amenaza para la salud de personas y animales. Los perturbadores efectos del cambio planetario han generado inestabilidad en los ecosistemas, por lo que resulta difícil predecir los resultados que van a deparar en el futuro los programas de gestión y control de las garrapatas y las enfermedades que transmiten. En particular, la selección de garrapatas resistentes a los acaricidas ha restado valor a estas sustancias como medio único de control. Las vacunas constituyen un método de lucha alternativo, aunque su utilización no ha avanzado desde que a principios de los años 90 se registraron las primeras vacunas contra garrapatas. Es preciso entender la compleja relación molecular entre anfitriones, garrapatas y patógenos, utilizar la biología de sistemas y aplicar métodos de vacunómica para descubrir proteínas dotadas de la función biológica pertinente en la alimentación, reproducción, desarrollo y respuesta inmunitaria de la garrapata, la alteración de la inmunidad del anfitrión y la transmisión del patógeno, factores todos ellos que determinan el éxito de la garrapata y el patógeno. También serán necesarios tales métodos para caracterizar posibles antígenos protectores y para validar formulaciones de vacuna. Las vacunas contra garrapatas que tienen un efecto dual (sobre las infestaciones por el parásito y la transmisión de patógenos) podrían reducir a la vez las infestaciones por garrapatas y su capacidad para transmitir enfermedades a personas, animales y anfitriones que constituyan un reservorio. La elaboración de estrategias integradas de lucha contra las garrapatas, que incluyan el uso de vacunas y el de acaricidas sintéticos y botánicos, junto con la gestión de la farmacorresistencia y una labor pedagógica dirigida a los productores, debería redundar en un control duradero de las garrapatas y las enfermedades que transmiten.
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